Restored archive. The original History Commons is no longer online; this is a read-only edition of its timelines. Content is licensed CC BY-NC-SA.

October 3 or 4, 1999: VIGOR Study Indicates Minimal Stomach Problems; No Evidence of Heart Problems

The VIGOR study’s safety panel has its first meeting. VIGOR, or the Vioxx Gastrointestinal Outcomes Research study, was designed to determine whether Vioxx causes fewer stomach problems than other painkillers on the market (see January 1999). Results as of October 1, 1999 suggest that patients taking Vioxx experience fewer ulcers and less gastrointestinal bleeding than those taking naproxen. [National Public Radio, 6/8/2006]